KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) EBIT Margin (2016 - 2025)

Elevance Health (ELV) has disclosed EBIT Margin for 17 consecutive years, with 6.03% as the latest value for Q2 2025.

  • On a quarterly basis, EBIT Margin rose 116040.0% to 6.03% in Q2 2025 year-over-year; TTM through Sep 2025 was 0.06%, a 482.0% decrease, with the full-year FY2024 number at 1.16%, up 9.0% from a year prior.
  • EBIT Margin was 6.03% for Q2 2025 at Elevance Health, down from 1.21% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 77.43% in Q4 2023 to a low of 1166.43% in Q2 2024.
  • A 5-year average of 102.68% and a median of 13.95% in 2023 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: tumbled -106737bps in 2024, then skyrocketed 116040bps in 2025.
  • Elevance Health's EBIT Margin stood at 103.3% in 2021, then grew by 25bps to 77.39% in 2022, then surged by 200bps to 77.43% in 2023, then tumbled by -459bps to 278.24% in 2024, then skyrocketed by 98bps to 6.03% in 2025.
  • Per Business Quant, the three most recent readings for ELV's EBIT Margin are 6.03% (Q2 2025), 1.21% (Q1 2025), and 278.24% (Q4 2024).